Avanos Medical, Inc.
AVNS
$12.43
$0.373.07%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9,339.53% | 138.89% | 300.00% | -108.57% | -- |
| Total Depreciation and Amortization | -5.13% | 3.54% | -0.88% | -0.87% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11,993.94% | -48.44% | 82.86% | 202.94% | -- |
| Change in Net Operating Assets | 1,116.22% | -55.42% | 137.73% | -272.88% | -- |
| Cash from Operations | 151.74% | -17.27% | 447.50% | -162.99% | -56.36% |
| Capital Expenditure | -60.00% | 49.15% | -43.90% | 30.51% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00% | -97.64% | -- |
| Other Investing Activities | 68.89% | -- | -- | -- | -- |
| Cash from Investing | 36.67% | -103.39% | -195.00% | -102.47% | 265.64% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -106.82% | -780.00% | 87.07% | 87.99% | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | 0.00% | 97.14% | 61.54% | -42.19% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | 100.00% | 95.73% | -- |
| Cash from Financing | -71.25% | -220.00% | -614.29% | 99.39% | -345.61% |
| Foreign Exchange rate Adjustments | -333.33% | 460.00% | 58.33% | -175.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 684.38% | -119.51% | 237.82% | 38.66% | -176.68% |